Shenandoah Therapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$21.5M
- Investors
-
5
Shenandoah Therapeutics General Information
Description
Developer of an oncology technology platform designed for cancer treatment. The company's platform utilizes a combination of proteins, including transcriptional chemical inducers of proximity, which trigger cancer cells to self-destruct, enabling medical professionals to offer new therapeutic options for cancer patients.
Contact Information
Website
www.shenandoah-tx.comCorporate Office
- 329 Oyster Point Boulevard
- 3rd Floor
- South San Francisco, CA 94080
- United States
Corporate Office
- 329 Oyster Point Boulevard
- 3rd Floor
- South San Francisco, CA 94080
- United States
Shenandoah Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 31-Mar-2025 | $21.5M | Completed | Stealth |
Shenandoah Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 |
Shenandoah Therapeutics Patents
Shenandoah Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026148150-A1 | Compositions and methods for treating autoimmune diseases | Pending | 31-Dec-2024 |
Shenandoah Therapeutics Signals
Shenandoah Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| First Spark Ventures | Venture Capital | Minority | ||
| Honghui Capital | Venture Capital | Minority | ||
| Samsara BioCapital | Venture Capital | Minority | ||
| Time BioVentures | Venture Capital | Minority | ||
| YK Bioventures | Venture Capital | Minority |
Shenandoah Therapeutics FAQs
-
When was Shenandoah Therapeutics founded?
Shenandoah Therapeutics was founded in 2022.
-
Where is Shenandoah Therapeutics headquartered?
Shenandoah Therapeutics is headquartered in South San Francisco, CA.
-
What is the size of Shenandoah Therapeutics?
Shenandoah Therapeutics has 5 total employees.
-
What industry is Shenandoah Therapeutics in?
Shenandoah Therapeutics’s primary industry is Discovery Tools (Healthcare).
-
Is Shenandoah Therapeutics a private or public company?
Shenandoah Therapeutics is a Private company.
-
What is the current valuation of Shenandoah Therapeutics?
The current valuation of Shenandoah Therapeutics is .
-
What is Shenandoah Therapeutics’s current revenue?
The current revenue for Shenandoah Therapeutics is .
-
How much funding has Shenandoah Therapeutics raised over time?
Shenandoah Therapeutics has raised $21.5M.
-
Who are Shenandoah Therapeutics’s investors?
First Spark Ventures, Honghui Capital, Samsara BioCapital, Time BioVentures, and YK Bioventures have invested in Shenandoah Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process